GMED
Globus Medical Stock Analysis
AI Rating
- Quality9/10
- Growth↑ 9/10
- Momentum↑ 7/10
GMED Growth
- Revenue Y/Y↑ 11.75%
- EPS Y/Y↑ 404.84%
- FCF Y/Y↑ 97.30%
GMED Profitability
- Gross margin ↑ 65.30%
- EPS margin↑ 15.30%
- ROIC↑ 22.70%
GMED Risk
- Debt / Equity↓ 0.0
- Debt / FCF↓ 0.0
- Interest coverage↑ 98.2
Globus Medical stock volatility is in-line with the overall market. We give it a Great risk rating.